PAPER Li B, Mu H, Shan D, Yang Y, Wang Y, Li J, Wang H, Sun X, Ji X, Zhan Z, Jiao Y, Tang Y, Kong B, Gao B, Wang Y, Sun P, Liu F

Generation of an induced pluripotent stem cell (iPSC) line (INNDSUi009-A) from a patient with amyotrophic lateral sclerosis due to SOD1 mutation.

Stem Cell Res. 2025 Mar 31;85:103704. Epub 2025 Mar 31 PubMed.

PAPER Landon B, Subasinghe K, Sumien N, Phillips N

miRNA and piRNA differential expression profiles in Alzheimer's disease: A potential source of pathology and tool for diagnosis.

Exp Gerontol. 2025 Apr 1;204:112745. Epub 2025 Apr 1 PubMed.

PAPER Ng TK, Beck T, Liu X, Desai P, Holland T, Dhana K, Krueger K, Wilson RS, Evans DA, Rajan KB

Longitudinal associations between lipid panel and cognitive decline modified by APOE 4 carrier status in biracial community-dwelling older adults: Findings from the Chicago health and aging project.

Arch Gerontol Geriatr. 2025 Mar 18;134:105825. Epub 2025 Mar 18 PubMed.

PAPER Haque A, Alenezi KM, Abdul Rasheed MS, Rahman MA, Anwar S, Ahamad S, Gupta D

Experimental and theoretical studies on structural changes in the microtubule affinity-regulating kinase 4 (MARK4) protein induced by N-hetarenes: a new class of therapeutic candidates for Alzheimer's disease.

Front Med (Lausanne). 2025;12:1529845. Epub 2025 Mar 19 PubMed.

PAPER Tonelli E, Malecka J, Barberis E, Romano C, Pessolano E, Talmon M, Genazzani AA, Casali C, Biggiogera M, Manfredi M, Tapella L, Lim D, Dematteis G

Remodelling of Cellular Protein Homeostasis by Enhanced ER-Mitochondrial Tethering.

Contact (Thousand Oaks). 2025;8:25152564251329704. Epub 2025 Apr 1 PubMed.

PAPER Sun Y, Liu Z, Zhang Z, Kang Y, Wang X, Zhang Y, Liu Y, Zhao P

Human induced pluripotent stem cell models for Alzheimer's disease research: a bibliometric analysis.

Front Hum Neurosci. 2025;19:1548701. Epub 2025 Mar 19 PubMed.

PAPER Alrouji M, Alshammari MS, Majrashi TA, Zuberi A, Shahwan M, Atiya A, Shamsi A

Unraveling human transferrin-tryptamine interactions: a computational and biophysical approach to Alzheimer's disease therapeutics.

Front Pharmacol. 2025;16:1540736. Epub 2025 Mar 19 PubMed.

PAPER Nahar L, Charoensup R, Kalieva K, Habibi E, Guo M, Wang D, Kvasnica M, Onder A, Sarker SD

Natural products in neurodegenerative diseases: recent advances and future outlook.

Front Pharmacol. 2025;16:1529194. Epub 2025 Mar 19 PubMed.

PAPER Zhou M, Tang AS, Zhang H, Xu Z, Ke AM, Su C, Huang Y, Mantyh WG, Jaffee MS, Rankin KP, DeKosky ST, Zhou J, Guo Y, Bian J, Sirota M, Wang F

Identifying progression subphenotypes of Alzheimer's disease from large-scale electronic health records with machine learning.

J Biomed Inform. 2025 Apr 1;165:104820. Epub 2025 Apr 1 PubMed.

Interdisciplinary Tutorial Workshop on Aging & Brain Health- 3rd

CONFERENCE 2026-01-06 00:00:00-2026-01-08 00:00:00 Aspen Snowmass, Colorado 06 &#x2013 08 January 2026 0

Roderick Moore

Graduate Student
United States

Esther Rojo

, Spain

Jennifer Lombardo

United States

PAPER Abdi Z, Yong KX, Schott JM, Gatt A, Revesz T, Crutch SJ, Lashley T

Pathological Characterisation of Posterior Cortical Atrophy in Comparison With Amnestic Alzheimer's Disease.

Neuropathol Appl Neurobiol. 2025 Apr;51(2):e70007. PubMed.

PAPER Lashuel HA, Surmeier DJ, Simuni T, Merchant K, Caughey B, Soto C, Fares MB, Heym RG, Melki R

Alpha-synuclein seed amplification assays: Data sharing, standardization needed for clinical use.

Sci Adv. 2025 Apr 4;11(14):eadt7195. Epub 2025 Apr 2 PubMed.